Chunyi Li

Chunyi Li

Auto-generated profile, based on publicly available information

Chunyi Li

National Key Laboratory of Green Pesticide Key Laboratory of Green Pesticide and Agricultural Bioengineering Ministry of Education Center for R&D of Fine Chemicals of Guizhou University Guiyang 550025 China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2022 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
CLChunyi Li
Chunyi Li
RSRunjiang Song
Runjiang Song
SHSiqi He
Siqi He
SWSikai Wu
Sikai Wu
SWShang Wu
Shang Wu
BSBaoan Song
Baoan Song

13 March 2024 in Advanced Science
Verified
Journal Article
Open access
CWChunle Wei
Chunle Wei
CZChunni Zhao
Chunni Zhao
JLJiao Li
Jiao Li
CLChunyi Li
Chunyi Li
BSBaoan Song
Baoan Song
RSRunjiang Song
Runjiang Song
The control of potato virus Y (PVY) induced crop failure is a challengeable issue in agricultural chemistry. Although many anti‐PVY agents are designed to focus on the functionally important coat protein (CP) of virus, how these drugs act on CP to inactivate viral pathogenicity, remains largely unknown. Herein, a PVY CP inhibitor ‐3j (S) is disclosed, which is accessed by developing unusually efficient (up to 99% yield) and chemo‐selective (> 99:1 er in most cases) carbene‐catalyzed [3+4] cycloaddition reactions. Compound ‐3j bears a unique arylimidazole‐fused diazepine skeleton and shows chirality‐preferred performance against PVY. In addition, ‐3j (S) as a mediator allows ARG191 (R191) of CP to be identified as a key amino acid site responsible for intercellular movement of virions. R191 is further demonstrated to be critical for the interaction between PVY CP and the plant functional protein NtCPIP, enabling virions to cross plasmodesmata. This key step can be significantly inhibited through bonding with the ‐3j (S) to further impair pathogenic behaviors involving systemic infection and particle assembly. The study reveals the in‐depth mechanism of action of antiviral agents targeting PVY CP, and contributes to new drug structures and synthetic strategies for PVY management.